Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals

Active
NOI-OD-27-000001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

1

Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC – radiopharmaceuticals

DOCX, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts
Chris Ryssa Nix

Full Description

Show more

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.


This procurement is for a purchase order NTE $900,000 for FDA-approved radiopharmaceuticals for patient care by the Nuclear Medicine Division, Department of Radiology and Imaging Sciences at the NIH Clinical Center. CARDINAL HEALTH is a reputed and reliable FDA and US NRC vetted supplier of the required radiopharmaceuticals by the Clinical Center. Based on the past 25 years of contracting with this vendor, this vendor is the only acceptable vendor because they provide a comprehensive list of radiopharmaceuticals that uniquely meets the patient needs of the NIH Clinical Center. They are the only provider that can supply all radiopharmaceuticals that emit gamma, positrons, beta and/or alpha radiations. They also use a patented tungsten delivery system for dispensing the high energy positron radiopharmaceuticals. This system minimizes radiation exposure to the staff and the public, as well as meeting the weight standard that reduces the potential weightlifting injuries to the staff.


This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.500 This subpart authorizes the use of simplified procedures for the acquisition of supplies and services in amounts greater than the simplified acquisition threshold but not exceeding $9 million ($15 million for acquisitions as described in 13.500(c)), including options, if the contracting officer reasonably expects, based on the nature of the supplies or services sought, and on market research, that offers will include only commercial products or commercial services. Contracting officers may use any simplified acquisition procedure in this part, subject to any specific dollar limitation applicable to the particular procedure. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.


Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.


Notice Type: Notice of Intent


NAICS Code: 325412


PSC Code: 3650


Posted Date: 10/13/2026


Close Date: 10/19/2026 12pm EST


End User IC: Clinical Center


POC Name: Ryssa Nix


Email Address: Ryssa.nix@nih.gov

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
FERRIC SUBSULFATE S
Solicitation # SPE2DP-27-T-0086
Solicitation SPE2DP-27-T-0086 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Ferric Subsulfate Solution, Monsels. The requirement is for three packages, with each package containing twelve 8 ml bottles. This medical product is intended for direct application to surgical sites following the excision of diseased tissue. Critical storage restrictions prohibit the use of aluminum, carbon steel, copper, copper alloys, zinc, or nickel. The item is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Delivery is required within 20 days after order, with the original required delivery date set for April 9, 2026. The shipping terms are FOB Destination, with delivery points located at APO AE 09126-3865 and Flugplatz Spangdahlem, Germany. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Because the material is hazardous, the contractor must provide a Material Safety Data Sheet and ensure labeling complies with the Hazard Communication Standard 29 CFR 1910.1200. The contract incorporates several key Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including those regarding the Buy American and Balance of Payments Program, safeguarding covered defense information, and combating trafficking in persons. Inspection and acceptance will occur at the destination. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system. Offerors are identified under NAICS code 325412 and must provide necessary small business representations and certifications.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541380
New
Federal
NOI - A Non-Invasive Prognostic Biomarker - Circul
Solicitation # 75N98027Q00007
The National Institutes of Health (NIH), Office of the Director, intends to award a non-competitive, firm-fixed-price purchase order to the University of Alabama at Birmingham under solicitation 75N98027Q00007. This acquisition, conducted under FAR 12.603 and not expected to exceed the simplified acquisition threshold, provides research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker for chlorine-induced acute lung injury. The project leverages the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, an active aspiration pneumonitis biorepository, and existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics to establish mechanistic relationships that will support future rapid diagnostic and triage tools for chemical exposure. The scope of work includes measuring bronchoalveolar lavage protein content and cell counts, quantifying plasma cytokines and chemokines, analyzing lung mitochondrial DNA concentration, and evaluating epithelial sodium channel activity and alveolar fluid clearance. Performance will be conducted in Birmingham, Alabama, with histology scoring adhering to American Thoracic Society guidelines. This requirement is not set aside for small businesses and falls under NAICS code 541380. The procurement is governed by FAR and HHSAR regulations, including specific requirements for SAM registration and equal employment opportunity cooperation.
Testing Laboratories and Services

POSTED

about 9 hours ago

DEADLINE

in 10 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS